NPO insider files Form 144 to sell 2,541 shares via Charles Schwab

Rhea-AI Filing Summary

Enpro Inc. (NPO) filed a Form 144 notifying a proposed sale of 2,541 common shares through Charles Schwab & Co., Inc. on the NYSE, with an aggregate market value reported at $568,601.00 and total shares outstanding listed as 21,053,512. The shares reflect restricted stock lapses acquired as equity compensation on 02/12/2022 (538 shares), 02/15/2024 (537 shares) and 02/16/2024 (1,466 shares). The filing indicates no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Full provenance disclosed: acquisition dates and nature (restricted stock lapse) are provided for all 2,541 shares
• No recent sales in the past three months are reported, simplifying aggregation considerations under Rule 144

Negative

• No trading-plan date provided: the filing does not state a 10b5-1 plan adoption date or trading instruction date
• No sale price disclosed: the form reports aggregate market value but not the intended sale price per share or range

Insights

Securities Analyst

TL;DR: Routine officer/insider sale notice for 2,541 shares; no recent sales reported and acquisition via equity compensation.

This Form 144 is procedural: it notifies the market that a person covered by Rule 144 intends to sell 2,541 Enpro common shares through Charles Schwab on the NYSE, with an aggregate market value shown as $568,601.00. The underlying shares resulted from restricted stock lapses granted as equity compensation on three separate dates in 2022 and 2024. The filer reports no sales in the prior three months and affirms no undisclosed material adverse information. For investors, this filing documents an intended sale but does not provide pricing, plan details, or indicate agreement breaches.

Corporate Governance Expert

TL;DR: Standard compliance filing showing disposition of equity-compensation shares; disclosure aligns with Rule 144 requirements.

The submission details provenance of the shares (restricted stock lapse) and the broker handling the transaction, meeting the disclosure expectations for an insider sale notice. It includes the statutory attestation regarding material nonpublic information and notes no aggregated sales in the prior three months. The filing does not include any trading-plan adoption date or 10b5-1 details, so no conclusions can be drawn about prearranged trading instructions from this form alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	2541	568601.00	21053512	08/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2022	Restricted Stock Lapse	ENPRO INC.			538	02/12/2022	Equity Compensation
Common	02/15/2024	Restricted Stock Lapse	ENPRO INC.			537	02/15/2024	Equity Compensation
Common	02/16/2024	Restricted Stock Lapse	ENPRO INC.			1466	02/16/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Enpro's (NPO) Form 144 report?

The Form 144 notifies a proposed sale of 2,541 common shares through Charles Schwab on the NYSE with an aggregate market value of $568,601.00.

When were the shares acquired that are being sold?

The shares were acquired via restricted stock lapses on 02/12/2022 (538 shares), 02/15/2024 (537 shares) and 02/16/2024 (1,466 shares).

Does the Form 144 show any sales in the past three months for NPO?

The filing states "Nothing to Report" for securities sold during the past three months.

Who is the broker handling the proposed sale?

The broker listed is Charles Schwab & Co., Inc. located at 3000 Schwab Way, Westlake TX; the sale is to occur on the NYSE.

Does the filing indicate the seller knows of any undisclosed material information?

By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.